| Dimethyl fumarate induces ferroptosis and impairs NF-κB/STAT3 signaling in DLBCL A Schmitt, W Xu, P Bucher, M Grimm, M Konantz, H Horn, M Zapukhlyak, ... Blood, The Journal of the American Society of Hematology 138 (10), 871-884, 2021 | 113 | 2021 |
| NF-κB activation in lymphoid malignancies: genetics, signaling, and targeted therapy P Grondona, P Bucher, K Schulze-Osthoff, S Hailfinger, A Schmitt Biomedicines 6 (2), 38, 2018 | 65 | 2018 |
| Keratinocyte-derived IκBζ drives psoriasis and associated systemic inflammation S Lorscheid, A Müller, J Löffler, C Resch, P Bucher, FC Kurschus, ... Jci Insight 4 (22), 2019 | 40 | 2019 |
| The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma J Bauer, N Köhler, Y Maringer, P Bucher, T Bilich, M Zwick, S Dicks, ... Nature Communications 13 (1), 6401, 2022 | 31 | 2022 |
| Targeting chronic NFAT activation with calcineurin inhibitors in diffuse large B-cell lymphoma P Bucher, T Erdmann, P Grondona, W Xu, A Schmitt, C Schürch, ... Blood, The Journal of the American Society of Hematology 135 (2), 121-132, 2020 | 31 | 2020 |
| Chemically induced mouse liver tumors are resistant to treatment with atorvastatin A Braeuning, P Bucher, U Hofmann, A Buchmann, M Schwarz BMC cancer 14, 1-10, 2014 | 20 | 2014 |
| Threonine phosphorylation of IκBζ mediates inhibition of selective proinflammatory target genes P Grondona, P Bucher, A Schmitt, C Schönfeld, B Streibl, A Müller, ... Journal of Investigative Dermatology 140 (9), 1805-1814. e6, 2020 | 8 | 2020 |
| Inhibition of glutaminase-1 in DLBCL potentiates venetoclax-induced antitumor activity by promoting oxidative stress B Gomez Solsona, H Horn, A Schmitt, W Xu, P Bucher, A Heinrich, ... Blood advances 7 (24), 7433-7444, 2023 | 2 | 2023 |
| LINKing signaling domains to enhance CAR T cells P Bucher, J Feucht Nature Cancer 4 (4), 447-449, 2023 | 1 | 2023 |
| Importance of NFAT and NF-κB signaling in Diffuselarge B-cell lymphoma P Bucher Universität Tübingen, 2023 | | 2023 |
| The oncogenic fusion protein DNAJB1-PRKACA can be actively targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma J Bauer, N Köhler, Y Maringer, P Bucher, T Bilich, M Zwick, S Dicks, ... Cancer Research 82 (12_Supplement), 2008-2008, 2022 | | 2022 |
| Phenobarbital-mediated tumor promotion in Apc knockout mice A Braeuning, A Gavrilov, P Bucher, U Metzger, C Wenz, M Templin, ... NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY 387, S31-S31, 2014 | | 2014 |
